STOCKCHASE

What the experts are saying!
This site compiles comments that experts make about stocks while on public TV shows.

There are 2 registered members and 51 guests viewing the site.

NUCRYST Pharmaceuticals Corp.
Symbol: NCS-T
Active: N
Sector: biotechnology/pharmaceutical
Last Price: 1.870
Last Price Date: 2010-02-12 02:20:22
Globe 200 day average


DON'T BUY	2.990	Michael Smedley	Their acne treatment was not approved previously by the FDA, but suddenly was in July.. The approval isn’t doing a great deal for it.	2007-09-24

PAST TOP PICK	2.960	Michael Smedley	(A Top Pick Aug 24/06. Down 79.5%.) Their cream for treating acne did not get approved by the FDA, but did get approval 2 weeks ago. It might still be interesting. Sold his holdings.	2007-08-03

PAST TOP PICK	6.900	Michael Smedley	(A Top Pick Aug 24/06. Down 52%.) Something went wrong with silver ointment treatment. They are back with silver bandaging. Based on the bandaging, it will be trading at 8-9 X earnings.	2006-10-19

TOP PICK	14.600	Michael Smedley	The Silcryst bandaging spin off from Westaim (WED-T). (They still hold about 75%). Have developed/patented a technology for reducing nanotechnology silver to its crystalline level for application in ointments. Getting great revenues. Highly speculative.	2006-08-24